SOCIETE LA PHARMACIE PIERRE ET FLORENCE CONCIATORI
SIREN : 344411327
Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 1988-01-01 (38 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MARSEILLE (13004), Bouches-du-Rhone
SOCIETE LA PHARMACIE PIERRE ET FLORENCE CONCIATORI : revenue, balance sheet and financial ratios
SOCIETE LA PHARMACIE PIERRE ET FLORENCE CONCIATORI is a French company
founded 38 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MARSEILLE (13004),
this company of category PME
shows in 2017 a revenue of 1.4 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SOCIETE LA PHARMACIE PIERRE ET FLORENCE CONCIATORI (SIREN 344411327)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
1 426 359 €
1 448 180 €
Net income
15 576 €
17 115 €
68 178 €
58 879 €
54 157 €
48 233 €
16 263 €
16 915 €
48 140 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
35 976 €
57 769 €
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
1.2%
3.3%
Revenue and income statement
In 2024, SOCIETE LA PHARMACIE PIERRE ET FLORENCE CONCIATORI generates positive net income of 16 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 48 k€ -> 16 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
15 576 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 20%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 70%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
19.582%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
70.387%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SOCIETE LA PHARMACIE PIERRE ET FLORENCE CONCIATORI
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
9.469
27.709
21.655
16.473
15.816
15.609
14.751
15.582
19.582
Financial autonomy
76.321
67.119
71.985
75.033
72.884
75.27
73.135
72.594
70.387
Repayment capacity
1.516
6.796
None
None
None
None
None
None
None
Cash flow / Revenue
3.482%
2.227%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
19.582024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Good
In 2024, the debt ratio of SOCIETE LA PHARMACIE PIER... (19.58) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
70.39%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent
In 2024, the financial autonomy of SOCIETE LA PHARMACIE PIER... (70.4%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 172.42. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
172.42
Liquidity indicators evolution SOCIETE LA PHARMACIE PIERRE ET FLORENCE CONCIATORI
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
178.727
160.044
164.147
179.403
178.569
219.645
206.531
172.496
172.42
Interest coverage
5.944
10.49
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
172.422024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Average-7 pts over 3 years
In 2024, the liquidity ratio of SOCIETE LA PHARMACIE PIER... (172.42) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SOCIETE LA PHARMACIE PIERRE ET FLORENCE CONCIATORI
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
161 284 €
166 214 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
36
40
0
0
0
0
0
0
0
Customer payment term (days)
8
5
0
0
0
0
0
0
0
Supplier payment term (days)
33
39
0
0
0
0
0
0
0
Positioning of SOCIETE LA PHARMACIE PIERRE ET FLORENCE CONCIATORI in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SOCIETE LA PHARMACIE PIERRE ET FLORENCE CONCIATORI is estimated at
217 452 €
(range 151 430€ - 325 321€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
151k€217k€325k€
217 452 €Range: 151 430€ - 325 321€
NAF 5 année 2024
Valuation method used
Net Income Multiple
15 576 €
×
14.0x
=217 452 €
Range: 151 430€ - 325 321€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SOCIETE LA PHARMACIE PIERRE ET FLORENCE CONCIATORI with other companies in the same sector:
Frequently asked questions about SOCIETE LA PHARMACIE PIERRE ET FLORENCE CONCIATORI
What is the revenue of SOCIETE LA PHARMACIE PIERRE ET FLORENCE CONCIATORI ?
The revenue of SOCIETE LA PHARMACIE PIERRE ET FLORENCE CONCIATORI in 2017 is 1.4 M€.
Is SOCIETE LA PHARMACIE PIERRE ET FLORENCE CONCIATORI profitable?
Yes, SOCIETE LA PHARMACIE PIERRE ET FLORENCE CONCIATORI generated a net profit of 16 k€ in 2024.
Where is the headquarters of SOCIETE LA PHARMACIE PIERRE ET FLORENCE CONCIATORI ?
The headquarters of SOCIETE LA PHARMACIE PIERRE ET FLORENCE CONCIATORI is located in MARSEILLE (13004), in the department Bouches-du-Rhone.
Where to find the tax return of SOCIETE LA PHARMACIE PIERRE ET FLORENCE CONCIATORI ?
The tax return of SOCIETE LA PHARMACIE PIERRE ET FLORENCE CONCIATORI is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SOCIETE LA PHARMACIE PIERRE ET FLORENCE CONCIATORI operate?
SOCIETE LA PHARMACIE PIERRE ET FLORENCE CONCIATORI operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart